Download
s11060-020-03467-y.pdf 2,29MB
WeightNameValue
1000 Titel
  • High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients
1000 Autor/in
  1. Hönikl, Lisa Stefanie |
  2. Lämmer, Friederike |
  3. Gempt, Jens |
  4. Meyer, Bernhard |
  5. Schlegel, Jürgen |
  6. Delbridge, Claire |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-04-02
1000 Erschienen in
1000 Quellenangabe
  • 147(3):567-575
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11060-020-03467-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256026/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Introduction!#!Glioblastoma multiforme (GBM) is a highly malignant glial tumor, affecting men more often than women. The reason for this gender-specific predominance remains unclear, raising the question whether these effects are subject to hormonal control. The purpose of this study was to examine the expression of estrogen receptor alpha (ERα) and aromatase in human GBM tissue samples in relation to patient survival and furthermore to investigate the effect of standard chemotherapy in combination with estradiol treatment on glioblastoma tumor cell lines in vitro.!##!Methods!#!60 tissue samples (31 male, 29 female) of GBM patients were analysed with immunohistochemistry for ERα and aromatase for survival analyses. The cell lines LN18 and LN229 were treated with 17β-estradiol (E2) in different dosing regimens and the cell viability was measured with MTT assay. After estradiol pre-treatment Temozolomide was added and tested again.!##!Results!#!High expression of ERα and aromatase in the GBM tissue samples was associated with significantly longer survival times of GBM patients, regardless of gender and body-mass-index. The treatment with high concentrations of estradiol resulted in lower tumor cell viability, compared to control. The cells significantly showed a stronger sensitivity against Temozolomid (TMZ) after estradiol pre-treatment.!##!Conclusion!#!ERα-expression of glial tumour cells seems to play an important prognostic role as a biomarker in GBM, as well as the expression of the enzyme Aromatase. The combined treatment of GBM with standard chemotherapy and estradiol may be beneficial to patient's survival.
1000 Sacherschließung
lokal TMZ
lokal Female [MeSH]
lokal Cell Line, Tumor [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Adult [MeSH]
lokal Estrogen receptor alpha
lokal Kaplan-Meier Estimate [MeSH]
lokal Humans [MeSH]
lokal Laboratory Investigation
lokal Glioblastoma multiforme
lokal Middle Aged [MeSH]
lokal Glioblastoma/metabolism [MeSH]
lokal Neuroglia/metabolism [MeSH]
lokal 17β-estradiol
lokal Aromatase/metabolism [MeSH]
lokal Survival
lokal Male [MeSH]
lokal Aromatase
lokal Estrogen Receptor alpha/metabolism [MeSH]
lokal Sex Characteristics [MeSH]
lokal Brain Neoplasms/metabolism [MeSH]
lokal Combined therapy in vitro
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SMO2bmlrbCwgTGlzYSBTdGVmYW5pZQ==|https://frl.publisso.de/adhoc/uri/TMOkbW1lciwgRnJpZWRlcmlrZQ==|https://frl.publisso.de/adhoc/uri/R2VtcHQsIEplbnM=|https://frl.publisso.de/adhoc/uri/TWV5ZXIsIEJlcm5oYXJk|https://frl.publisso.de/adhoc/uri/U2NobGVnZWwsIErDvHJnZW4=|https://frl.publisso.de/adhoc/uri/RGVsYnJpZGdlLCBDbGFpcmU=
1000 Hinweis
  • DeepGreen-ID: bcf823b36c7d41babe6043ec87f3030e ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6470816.rdf
1000 Erstellt am 2023-11-18T09:01:39.458+0100
1000 Erstellt von 322
1000 beschreibt frl:6470816
1000 Zuletzt bearbeitet 2023-12-01T12:58:27.156+0100
1000 Objekt bearb. Fri Dec 01 12:58:27 CET 2023
1000 Vgl. frl:6470816
1000 Oai Id
  1. oai:frl.publisso.de:frl:6470816 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source